Vitaspring Biomedical Co. Ltd. SEC filings VSBC

Vitaspring Biomedical Co. Ltd. has 74 filings in SEC EDGAR's recent list, going back to Mar 6, 2017. Its latest annual report, Form 10-K, was filed on Jun 17, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 17, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change). The company's fiscal year ends on January 31.

Form Description Filed Period
10-K Annual report Jun 17, 2026 Jan 31, 2026
10-K Annual report Jun 8, 2026 Jan 31, 2025
10-K Annual report Mar 12, 2026 Jan 31, 2024
10-K Annual report Dec 1, 2025 Jan 31, 2023
10-K Annual report May 3, 2022 Jan 31, 2022
10-K Annual report Apr 14, 2021 Jan 31, 2021
10-K Annual report Jun 9, 2020 Jan 31, 2020
10-K Annual report Apr 26, 2019 Jan 31, 2019
10-K Annual report May 16, 2018 Jan 31, 2018

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
VSBC (OTC)
Fiscal year ends
January 31
Incorporated in
NV
Headquarters
Riverside, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1697884
Former names
Shemn Corp. (until Apr 27, 2020)

Other Services-Commercial Physical & Biological Research companies

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.